EUVIMEDDescubrir EUVIMED
Open access · CC BY-NC-ND 4.0

Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study

Kevin Ferrari iD, Alice Aarnink, Carole Ayav, Luc Frimat, Cécile Couchoud, Benoît Audry, Corinne Antoine, Sophie Girerd iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15160 ↗

At a glance

Journal article in Clinical Transplantation, 2024. Written by Kevin Ferrari and 7 co-authors. Institution: Nephrology Department, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France. Major MEDLINE topics: Kidney Transplantation, Renal Insufficiency. Cited 4 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Background

The optimal management of immunosuppressive therapy (IT) after kidney allograft failure (KAF) remains controversial. Although maintaining IT may reduce HLA‐sensitization and improve access to retransplantation, it may also increase the rate of immunosuppression‐related complications. The overall impact on patient mortality is unknown. The main objective of this study was to compare the evolution of HLA‐sensitization 6 months after KAF according to IT management.

Methods

Individual clinical and health care data were extracted from the French national end‐stage kidney disease registry (Renal Epidemiology and Information Network [REIN]) and the French National Health Data system (SNDS), respectively. Patients aged > 18 years returning to dialysis after KAF between January 2008 and December 2019 in Lorraine were included. Patients were classified into two groups, IT continuation or IT discontinuation. HLA‐sensitization was defined as an increase in incompatible graft rate (IGR) between KAF and 6 months post‐KAF (change to a higher predefined category (0%–5%), (5%–20%), (20%–50%), (50%–85%), (85%–95%), (95%–98%), (98%–100%)). Secondary outcome was patient survival according to IT management.

Results

A total of 121 patients were included, 35 (29%) of whom continued IT. HLA‐sensitization after KAF tended to be higher in the “IT discontinuation” group (57% vs. 38% in the “IT continuation” group, p = .07). In multivariate analysis, IT continuation was associated with a lower increase in IGR (OR .37, 95% CI [.14; .93]). IT management was not associated with patient mortality.

Conclusions

Continuation of IT after KAF was associated with less change in IGR and was not associated with excess mortality.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationRenal InsufficiencyHumansRenal DialysisRetrospective StudiesKidneyImmunosuppression TherapyGraft RejectionGraft Survival

Author keywords

HLAgraft nephrectomyimmunosuppressive therapykidney graft failurekidney transplantationsensitization

Authors and institutions

  • Nephrology Department, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
  • Histocompatibility Laboratory, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
  • IMoPA6, UMR7365 CNRS, Université de Lorraine, Vandoeuvre-les-Nancy, France.
  • Clinical Epidemiology, Inserm CIC-EC, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
  • Agence de la Biomédecine, Saint-Denis, France.
  • Université de Lorraine, Inserm, Centre d'Investigation Clinique-1433, and Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT, Nancy, France.

ORCID profiles: Kevin Ferrari, Sophie Girerd

Cite

APA

Ferrari, K., Aarnink, A., Ayav, C., Frimat, L., Couchoud, C., Audry, B., Antoine, C., & Girerd, S. (2024). Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study. Clinical Transplantation. https://doi.org/10.1111/ctr.15160

Vancouver

Ferrari K, Aarnink A, Ayav C, Frimat L, Couchoud C, Audry B, et al. Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study. Clinical Transplantation. 2024. doi:10.1111/ctr.15160

BibTeX
@article{Ferrari2024,
  author = {Ferrari, Kevin and Aarnink, Alice and Ayav, Carole and Frimat, Luc and Couchoud, Cécile and Audry, Benoît and Antoine, Corinne and Girerd, Sophie},
  title = {Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15160}
}
Start for free →